Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00965055 · ClinicalTrials.gov registry record · Phase 3
Ezetimibe in Patients Hypo-responsive to Statins
A Phase 3 study, sponsored by University of California, San Diego.
- Terminated
- Registry status
- Phase 3
- Development phase
- 2
- Enrollment target
NCT00965055: Clinical Trial Phase 3 study, sponsored by University of California, San Diego.
NCT00965055 is a Phase 3 study that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 2 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00965055, a Phase 3 study, was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 2 participants
- Enrollment target
Study Summary
Response to statin therapy for elevated low density lipoprotein is variable and may be influenced by cholesterol absorption. This study will evaluate whether combination therapy with atorvastatin/ezetimibe will be superior to atorvastatin alone in subjects who have less than 25% LDL reduction on starting dose statin (eg, atorvastatin 10 mg daily or simvastatin 20 mg daily).
Primary Outcome
Study was not analyzed as only 2 subjects were enrolled and the study was terminated due to lack of enrollment.
Interventions
- DRUG Ezetimibe
- DRUG Atorvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-09 |
| Phase | Phase 3 |
Why NCT00965055 stopped before completion
NCT00965055 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Ezetimibe is the first listed.
NCT00965055 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00965055 about?
NCT00965055 is a clinical study titled "Ezetimibe in Patients Hypo-responsive to Statins". Response to statin therapy for elevated low density lipoprotein is variable and may be influenced by cholesterol absorption. This study will evaluate whether combination therapy with atorvastatin/ezetimibe will be superior to atorvastatin alone in subjects who have less than 25% LDL reduction on sta...
What is the current status of trial NCT00965055?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 2 participants. The study started on 2009-09. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00965055?
The interventions under investigation include: Ezetimibe (DRUG), Atorvastatin (DRUG).
Who is sponsoring clinical trial NCT00965055?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00965055's enrollment target sits among peer trials
2 2000th of 2000 the lowest of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia